Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Inhibitors of ORAI1 Prevent Cytosolic Calcium-Associated Injury of Human Pancreatic Acinar Cells and Acute Pancreatitis in 3 Mouse Models.

Wen L, Voronina S, Javed MA, Awais M, Szatmary P, Latawiec D, Chvanov M, Collier D, Huang W, Barrett J, Begg M, Stauderman K, Roos J, Grigoryev S, Ramos S, Rogers E, Whitten J, Velicelebi G, Dunn M, Tepikin AV, Criddle DN, Sutton R.

Gastroenterology. 2015 Aug;149(2):481-92.e7. doi: 10.1053/j.gastro.2015.04.015. Epub 2015 Apr 25.

2.

Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.

Kounnas MZ, Danks AM, Cheng S, Tyree C, Ackerman E, Zhang X, Ahn K, Nguyen P, Comer D, Mao L, Yu C, Pleynet D, Digregorio PJ, Velicelebi G, Stauderman KA, Comer WT, Mobley WC, Li YM, Sisodia SS, Tanzi RE, Wagner SL.

Neuron. 2010 Sep 9;67(5):769-80. doi: 10.1016/j.neuron.2010.08.018.

3.

Is alpha-T catenin (VR22) an Alzheimer's disease risk gene?

Bertram L, Mullin K, Parkinson M, Hsiao M, Moscarillo TJ, Wagner SL, Becker KD, Velicelebi G, Blacker D, Tanzi RE.

J Med Genet. 2007 Jan;44(1):e63.

4.

High-throughput assessment of mitochondrial membrane potential in situ using fluorescence resonance energy transfer.

Dykens JA, Fleck B, Ghosh S, Lewis M, Velicelebi G, Ward MW.

Mitochondrion. 2002 May;1(5):461-73.

PMID:
16120299
5.

STIM1, an essential and conserved component of store-operated Ca2+ channel function.

Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, Zhang S, Safrina O, Kozak JA, Wagner SL, Cahalan MD, Veliçelebi G, Stauderman KA.

J Cell Biol. 2005 May 9;169(3):435-45. Epub 2005 May 2.

6.

Family-based association between Alzheimer's disease and variants in UBQLN1.

Bertram L, Hiltunen M, Parkinson M, Ingelsson M, Lange C, Ramasamy K, Mullin K, Menon R, Sampson AJ, Hsiao MY, Elliott KJ, Velicelebi G, Moscarillo T, Hyman BT, Wagner SL, Becker KD, Blacker D, Tanzi RE.

N Engl J Med. 2005 Mar 3;352(9):884-94.

7.

Genetic association of Alzheimer's disease with multiple polymorphisms in alpha-2-macroglobulin.

Saunders AJ, Bertram L, Mullin K, Sampson AJ, Latifzai K, Basu S, Jones J, Kinney D, MacKenzie-Ingano L, Yu S, Albert MS, Moscarillo TJ, Go RC, Bassett SS, Daly MJ, Laird NM, Wang X, Velicelebi G, Wagner SL, Becker DK, Tanzi RE, Blacker D.

Hum Mol Genet. 2003 Nov 1;12(21):2765-76. Epub 2003 Sep 9.

PMID:
12966032
8.

Characterization of the recombinant human neuronal nicotinic acetylcholine receptors alpha3beta2 and alpha4beta2 stably expressed in HEK293 cells.

Chavez-Noriega LE, Gillespie A, Stauderman KA, Crona JH, Claeps BO, Elliott KJ, Reid RT, Rao TS, Velicelebi G, Harpold MM, Johnson EC, Corey-Naeve J.

Neuropharmacology. 2000 Oct;39(13):2543-60.

PMID:
11044726
9.

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.

Gasparini F, Lingenhöhl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Veliçelebi G, Kuhn R.

Neuropharmacology. 1999 Oct;38(10):1493-503.

PMID:
10530811
10.

SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5.

Varney MA, Cosford ND, Jachec C, Rao SP, Sacaan A, Lin FF, Bleicher L, Santori EM, Flor PJ, Allgeier H, Gasparini F, Kuhn R, Hess SD, Veliçelebi G, Johnson EC.

J Pharmacol Exp Ther. 1999 Jul;290(1):170-81.

PMID:
10381773
11.

Stable expression of human NMDA receptors in cultured mammalian cells.

Varney MA, Lin FF, Jachec C, Rao SP, Hess SD, Johnson EC, Veliçelebi G.

Methods Mol Biol. 1999;128:43-59. Review. No abstract available.

PMID:
10320972
12.

Fluorescence techniques for measuring ion channel activity.

Veliçelebi G, Stauderman KA, Varney MA, Akong M, Hess SD, Johnson EC.

Methods Enzymol. 1999;294:20-47. No abstract available.

PMID:
9916221
13.

The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression.

Daggett LP, Johnson EC, Varney MA, Lin FF, Hess SD, Deal CR, Jachec C, Lu CC, Kerner JA, Landwehrmeyer GB, Standaert DG, Young AB, Harpold MM, Veliçelebi G.

J Neurochem. 1998 Nov;71(5):1953-68.

14.

The potential of subtype-selective neuronal nicotinic acetylcholine receptor agonists as therapeutic agents.

Lloyd GK, Menzaghi F, Bontempi B, Suto C, Siegel R, Akong M, Stauderman K, Velicelebi G, Johnson E, Harpold MM, Rao TS, Sacaan AI, Chavez-Noriega LE, Washburn MS, Vernier JM, Cosford ND, McDonald LA.

Life Sci. 1998;62(17-18):1601-6. Review.

PMID:
9585143
15.

Pharmacological characterization of the human ionotropic glutamate receptor subtype GluR3 stably expressed in mammalian cells.

Varney MA, Rao SP, Jachec C, Deal C, Hess SD, Daggett LP, Lin F, Johnson EC, Veliçelebi G.

J Pharmacol Exp Ther. 1998 Apr;285(1):358-70.

PMID:
9536032
16.

Functional characterization of human N-methyl-D-aspartate subtype 1A/2D receptors.

Hess SD, Daggett LP, Deal C, Lu CC, Johnson EC, Veliçelebi G.

J Neurochem. 1998 Mar;70(3):1269-79.

17.

Characterization of human recombinant neuronal nicotinic acetylcholine receptor subunit combinations alpha2beta4, alpha3beta4 and alpha4beta4 stably expressed in HEK293 cells.

Stauderman KA, Mahaffy LS, Akong M, Veliçelebi G, Chavez-Noriega LE, Crona JH, Johnson EC, Elliott KJ, Gillespie A, Reid RT, Adams P, Harpold MM, Corey-Naeve J.

J Pharmacol Exp Ther. 1998 Feb;284(2):777-89.

PMID:
9454827
18.

Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.

Counihan TJ, Landwehrmeyer GB, Standaert DG, Kosinski CM, Scherzer CR, Daggett LP, Veliçelebi G, Young AB, Penney JB Jr.

J Comp Neurol. 1998 Jan 5;390(1):91-101.

PMID:
9456178
19.

Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex.

Scherzer CR, Landwehrmeyer GB, Kerner JA, Counihan TJ, Kosinski CM, Standaert DG, Daggett LP, Veliçelebi G, Penney JB, Young AB.

J Comp Neurol. 1998 Jan 5;390(1):75-90.

PMID:
9456177
20.

Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus.

Kosinski CM, Standaert DG, Counihan TJ, Scherzer CR, Kerner JA, Daggett LP, Veliçelebi G, Penney JB, Young AB, Landwehrmeyer GB.

J Comp Neurol. 1998 Jan 5;390(1):63-74.

PMID:
9456176
21.

Cloning and stable expression of the mGluR1b subtype of human metabotropic receptors and pharmacological comparison with the mGluR5a subtype.

Lin FF, Varney M, Sacaan AI, Jachec C, Daggett LP, Rao S, Flor P, Kuhn R, Kerner JA, Standaert D, Young AB, Veliçelebi G.

Neuropharmacology. 1997 Jul;36(7):917-31.

PMID:
9257936
22.

Cellular distribution of NMDA glutamate receptor subunit mRNAs in the human cerebellum.

Scherzer CR, Landwehrmeyer GB, Kerner JA, Standaert DG, Hollingsworth ZR, Daggett LP, Veliçelebi G, Penney JB Jr, Young AB.

Neurobiol Dis. 1997;4(1):35-46.

PMID:
9258910
23.

Comparative structure of human neuronal alpha 2-alpha 7 and beta 2-beta 4 nicotinic acetylcholine receptor subunits and functional expression of the alpha 2, alpha 3, alpha 4, alpha 7, beta 2, and beta 4 subunits.

Elliott KJ, Ellis SB, Berckhan KJ, Urrutia A, Chavez-Noriega LE, Johnson EC, Veliçelebi G, Harpold MM.

J Mol Neurosci. 1996 Fall;7(3):217-28.

PMID:
8906617
24.

Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells.

Varney MA, Jachec C, Deal C, Hess SD, Daggett LP, Skvoretz R, Urcan M, Morrison JH, Moran T, Johnson EC, Veliçelebi G.

J Pharmacol Exp Ther. 1996 Oct;279(1):367-78.

PMID:
8859015
25.

Cloning and functional characterization of human heteromeric N-methyl-D-aspartate receptors.

Hess SD, Daggett LP, Crona J, Deal C, Lu CC, Urrutia A, Chavez-Noriega L, Ellis SB, Johnson EC, Veliçelebi G.

J Pharmacol Exp Ther. 1996 Aug;278(2):808-16.

PMID:
8768735
26.

Profiling of trans-azetidine-2,4-dicarboxylic acid at the human metabotropic glutamate receptors mGlu1b, -2, -4a and -5a.

Knöpfel T, Sakaki J, Flor PJ, Baumann P, Sacaan AI, Veliçelebi G, Kuhn R, Allgeier H.

Eur J Pharmacol. 1995 Feb 15;288(3):389-92.

PMID:
7774685
27.

Human neuronal voltage-dependent calcium channels: studies on subunit structure and role in channel assembly.

Brust PF, Simerson S, McCue AF, Deal CR, Schoonmaker S, Williams ME, Veliçelebi G, Johnson EC, Harpold MM, Ellis SB.

Neuropharmacology. 1993 Nov;32(11):1089-102.

PMID:
8107964
28.

Structure and functional expression of an omega-conotoxin-sensitive human N-type calcium channel.

Williams ME, Brust PF, Feldman DH, Patthi S, Simerson S, Maroufi A, McCue AF, Veliçelebi G, Ellis SB, Harpold MM.

Science. 1992 Jul 17;257(5068):389-95.

PMID:
1321501
29.

Structure and functional expression of alpha 1, alpha 2, and beta subunits of a novel human neuronal calcium channel subtype.

Williams ME, Feldman DH, McCue AF, Brenner R, Velicelebi G, Ellis SB, Harpold MM.

Neuron. 1992 Jan;8(1):71-84.

PMID:
1309651
30.

Characterization of growth hormone releasing factor analog expression in Saccharomyces cerevisiae.

Craig WS, Wondrack L, Siegel R, Patthi S, Davis GR, Velicelebi G, Mowles TF, Thill GP.

Int J Pept Protein Res. 1991 Nov;38(5):401-8.

PMID:
1802859
33.

Development of helix-based vasoactive intestinal peptide analogues: identification of residues required for receptor interaction.

Musso GF, Patthi S, Ryskamp TC, Provow S, Kaiser ET, Veliçelebi G.

Biochemistry. 1988 Oct 18;27(21):8174-81.

PMID:
2852954
34.

Structural characterization of vasoactive intestinal peptide receptors from rat lung membranes.

Veliçelebi G, Patthi S, Provow S, Akong M, Simerson S.

Ann N Y Acad Sci. 1988;527:266-81. No abstract available.

PMID:
2839081
36.
37.
38.

Covalent cross-linking of growth hormone-releasing factor to pituitary receptors.

Veliçelebi G, Patthi S, Provow S, Akong M.

Endocrinology. 1986 Apr;118(4):1278-83.

PMID:
3004907
39.

Specific binding of synthetic human pancreatic growth hormone releasing factor (1-40-OH) to bovine anterior pituitaries.

Veliçelebi G, Santacroce TM, Harpold MM.

Biochem Biophys Res Commun. 1985 Jan 16;126(1):33-9.

PMID:
2982371
40.
41.

Scanning calorimetric investigation of the polymerization of the coat protein of tobacco mosaic virus.

Sturtevant JM, Velicelebi G, Jaenicke R, Lauffer MA.

Biochemistry. 1981 Jun 23;20(13):3792-800.

PMID:
7272276
42.

Calorimetric study of the interaction of lysozyme with aqueous 1-propanol.

Sturtevant JM, Velicelebi G.

Biochemistry. 1981 May 26;20(11):3091-6.

PMID:
7248270
43.

Observation of an exothermic process associated with the in vitro polymerization of brain tubulin.

Berkowitz SA, Velicelebi G, Sutherland JW, Sturtevant JM.

Proc Natl Acad Sci U S A. 1980 Aug;77(8):4425-9.

44.

Effect of single amino acid substitutions on the thermal stability of the alpha subunit of tryptophan synthase.

Matthews CR, Crisanti MM, Gepner GL, Velicelebi G, Sturtevant JM.

Biochemistry. 1980 Apr 1;19(7):1290-3. No abstract available.

PMID:
6992862
45.

Thermodynamics of the denaturation of lysozyme in alcohol--water mixtures.

Velicelebi G, Sturtevant JM.

Biochemistry. 1979 Apr 3;18(7):1180-6.

PMID:
427107

Supplemental Content

Loading ...
Support Center